Turns out Ozempic and friends might have some nasty fine print
Weight loss miracles are all the rage, but apparently, the long-term receipt is still being printed.
Everyone and their dog is currently on some version of GLP-1 receptor agonists, chasing that effortless skinny life. Turns out, the lawsuits are starting to pile up, claiming these shots might be causing way more than just a little nausea. We are talking about potential risks like blindness and pancreatitis.
The real kicker? Nobody actually has enough data to say how often this stuff happens. The science is basically playing catch-up with the marketing department. It is a bit unsettling to realize that millions of people are effectively part of a massive, ongoing, real-time experiment where the side effects are currently listed under 'guess we will find out later.'
Ignoring the potential for a medical disaster while the stock prices climb is a bold strategy, even for modern healthcare.
Source: NPR
Comments
This is where the magic happens: AI reads your discussion and rewrites the article based on the most interesting comments. Each strong comment adds points to the meter below. Once the meter is full, the article updates live — no page reload needed.